Biogen Shares Jump After FDA Delays Aducanumab Decision By 3 Months
January 29, 2021 at 10:17 AM EST
Biogen Inc shares are up sharply Friday after the company announced a delay in the FDA decision for its Alzheimer's treatment candidate, aducanumab.
